Learn More
Selleck Chemical LLC Olmutinib

Supplier: Selleck Chemical LLC S82945MG
Olmutinib (BI 1482694) is a novel third-generation epidermal growth factor receptor (EGFR) mutation-specific tyrosine kinase inhibitor (TKI) Also a potent inhibitor of Bruton s tyrosine kinase
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.